Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kerr

Showing results (871-880 of 966) with videos related to

Pageof 97
Sort By:
Journal of Clinical Pathology|October 19, 2006
Best practice in primary care pathology: review 7W S A Smellie, J Forth, S R S Smart, et al.
Internal Medicine Journal|September 12, 2017
Urolithiasis is prevalent and associated with reduced bone mineral density in β-thalassaemia majorPhillip Wong, Frances Milat, Peter J Fuller, et al.
Bioengineering (Basel, Switzerland)|June 18, 2020
Pseudopterosin and <i>O</i>-Methyltylophorinidine Suppress Cell Growth in a 3D Spheroid Co-Culture Model of Pancreatic Ductal AdenocarcinomaBailu Xie, Jan Hänsel, Vanessa Mundorf, et al.
Blood|February 25, 2005
Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cellsKuichun Zhu, Elvira Gerbino, Darrin M Beaupre, et al.
Nephrology (Carlton, Vic.)|March 27, 2015
Renal allograft re-use and herpetic re-infectionStella Setyapranata, Stephen G Holt, Kate J Wiggins, et al.
Endocrinology|September 10, 2003
Two basic amino acids C-terminal of the proximal box specify functional binding of the vitamin D receptor to its rat osteocalcin deoxyribonucleic acid-responsive elementJui-Cheng Hsieh, G Kerr Whitfield, Peter W Jurutka, et al.
Nephrology (Carlton, Vic.)|June 11, 2004
Atherosclerosis and folic acid supplementation trial in chronic renal failure: baseline resultsSophia Zoungas, Pauline Branley, Peter G Kerr, et al.
Future Oncology (London, England)|January 4, 2017
Phase II trial of capecitabine plus erlotinib versus capecitabine alone in patients with advanced colorectal cancerMark D Vincent, Daniel Breadner, Denis Soulieres, et al.
Nephrology (Carlton, Vic.)|February 7, 2018
Models of care for co-morbid diabetes and chronic kidney diseaseClement Lo, Edward Zimbudzi, Helena Teede, et al.
Molecular Medicine (Cambridge, Mass.)|October 22, 2025
SHIPi improves hematologic recovery after chemotherapySandra Fernandes, Chiara Pedicone, Otto M Dungan, et al.
Pageof 97

Showing results (871-880 of 966) with videos related to

Sort By:
Pageof 97
Journal of Clinical Pathology|October 19, 2006
Best practice in primary care pathology: review 7W S A Smellie, J Forth, S R S Smart, et al.
Internal Medicine Journal|September 12, 2017
Urolithiasis is prevalent and associated with reduced bone mineral density in β-thalassaemia majorPhillip Wong, Frances Milat, Peter J Fuller, et al.
Bioengineering (Basel, Switzerland)|June 18, 2020
Pseudopterosin and <i>O</i>-Methyltylophorinidine Suppress Cell Growth in a 3D Spheroid Co-Culture Model of Pancreatic Ductal AdenocarcinomaBailu Xie, Jan Hänsel, Vanessa Mundorf, et al.
Blood|February 25, 2005
Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cellsKuichun Zhu, Elvira Gerbino, Darrin M Beaupre, et al.
Nephrology (Carlton, Vic.)|March 27, 2015
Renal allograft re-use and herpetic re-infectionStella Setyapranata, Stephen G Holt, Kate J Wiggins, et al.
Endocrinology|September 10, 2003
Two basic amino acids C-terminal of the proximal box specify functional binding of the vitamin D receptor to its rat osteocalcin deoxyribonucleic acid-responsive elementJui-Cheng Hsieh, G Kerr Whitfield, Peter W Jurutka, et al.
Nephrology (Carlton, Vic.)|June 11, 2004
Atherosclerosis and folic acid supplementation trial in chronic renal failure: baseline resultsSophia Zoungas, Pauline Branley, Peter G Kerr, et al.
Future Oncology (London, England)|January 4, 2017
Phase II trial of capecitabine plus erlotinib versus capecitabine alone in patients with advanced colorectal cancerMark D Vincent, Daniel Breadner, Denis Soulieres, et al.
Nephrology (Carlton, Vic.)|February 7, 2018
Models of care for co-morbid diabetes and chronic kidney diseaseClement Lo, Edward Zimbudzi, Helena Teede, et al.
Molecular Medicine (Cambridge, Mass.)|October 22, 2025
SHIPi improves hematologic recovery after chemotherapySandra Fernandes, Chiara Pedicone, Otto M Dungan, et al.
Pageof 97